Michelle King

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Major Depressive Disorder

Clinical Decision Support

Top Venues

BJU international

BMC endocrine disorders

BMC health services research

This page only lists publications with an associated author ORCID identifier.

Publications

Wee Loon Ong, Krupa Krishnaprasad, Jonathan G Bensley, Michelle Steeper, Kerri Beckmann, Sibilah Breen, Michelle King, Stephen Mark, Michael E O'Callaghan, Manish Patel, Emma Tod, Jeremy L Millar, null null
Population-based prostate cancer outcomes registries - what have we learned and where are we heading? BJU international (2024)
Sibel Saya, Patty Chondros, Anastasia Gardner, Cathrine Mihalopolous, Mary Lou Chatterton, Jane Maree Gunn, Timothy Frank Chen, Thomas M Polasek, Elise Dettmann, Rachel Brooks, Michelle King, Luke Spencer, Pavithran Alphonse, Shakira R Onwuka, Georgia Ramsay, Zoe Siviour, Jamie Jm Liew, Philip Ly, Matthew Thoenig, Raushaan Seychell, Floriana La Rocca, Luke B Hesson, Nydia Mejias, Terri Sivertsen, Melanie Anne Galea, Chad A Bousman, Jon David Emery
The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care. Trials 24 (1) (2023)
Sibel Saya, Patty Chondros, Anastasia Gardner, Cathrine Mihalopolous, Mary Lou Chatterton, Jane Maree Gunn, Timothy Frank Chen, Thomas M Polasek, Elise Dettmann, Rachel Brooks, Michelle King, Luke Spencer, Pavithran Alphonse, Shakira R Onwuka, Georgia Ramsay, Zoe Siviour, Jamie Jm Liew, Philip Ly, Matthew Thoenig, Raushaan Seychell, Floriana La Rocca, Luke B Hesson, Nydia Mejias, Terri Sivertsen, Melanie Anne Galea, Chad A Bousman, Jon David Emery
The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care. Trials 24 (1) (2023)
Sibel Saya, Patty Chondros, Anastasia Gardner, Cathrine Mihalopolous, Mary Lou Chatterton, Jane Maree Gunn, Timothy Frank Chen, Thomas M Polasek, Elise Dettmann, Rachel Brooks, Michelle King, Luke Spencer, Pavithran Alphonse, Shakira R Onwuka, Georgia Ramsay, Zoe Siviour, Jamie Jm Liew, Philip Ly, Matthew Thoenig, Raushaan Seychell, Floriana La Rocca, Luke B Hesson, Nydia Mejias, Terri Sivertsen, Melanie Anne Galea, Chad A Bousman, Jon David Emery
The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care. Trials 24 (1) (2023)
Rodrigo Mariño, Andre Priede, Michelle King, Geoffrey G Adams, Maria Sicari, Mike Morgan
Oral health professionals screening for undiagnosed type-2 diabetes and prediabetes: the iDENTify study. BMC endocrine disorders 22 (1) (2022)
Rodrigo Mariño, Andre Priede, Michelle King, Geoffrey G Adams, Diego J Lopez
Attitudes and opinions of Oral healthcare professionals on screening for Type-2 diabetes. BMC health services research 21 (1) (2021)